Intraductal injection of the resulting virus (AAV-PT) into Cas9 rats led to tumors with a median latency of only 42 days, markedly faster than targeting either Tp53 or Pik3ca alone (Fig 1G), confirming the high synergy of these two most common breast cancer genes. Here, TP53 is linked to breast carcinoma.